Abstract: Disclosed are an automatic welding system and method for large structural parts based on hybrid robots and 3D vision. The system comprises a hybrid robot system composed of a mobile robot and an MDOF robot, a 3D vision system, and a welding system used for welding. The rough positioning technique based on a mobile platform and the accurate recognition and positioning technique based on high-accuracy 3D vision are combined, so the working range of the MDOF robot in the XYZ directions is expanded, and flexible welding of large structural parts is realized. The invention adopts 3D vision, thus having better error tolerance and lower requirements for the machining accuracy of workpieces, positioning accuracy of mobile robots and placement accuracy of the workpieces; and the cost is reduced, the flexibility is improved, the working range is expanded, labor is saved, production efficiency is improved, and welding quality is improved.

Abstract: The present disclosure provides an LED display module and an LED display device. The LED display module includes a display module body and a lock. The lock includes: a lock seat arranged on a rear side of the display module body; a lock cylinder rotatably arranged in the lock seat; a locking member; an interference member rotatably sleeved on the lock cylinder and spaced apart from the locking member along the axial direction of the lock cylinder, the interference member having an interference position where the interference member locates on a front side of a connecting beam for lifting up the display module body and an avoidance position where the interference member avoids the connecting beam; and an elastic linkage member arranged between the locking member and the interference member. When the locking member is in an unlocking position, the interference member is driven to an interference position by the elastic linkage member.

Abstract: The present invention relates to a process for the production of metal alloy nanoparticles which catalyse the oxygen reduction reaction (ORR) for use in proton exchange membrane fuel cells (PEMFC) or electrolyser cells. In particular, the present invention relates to a process for producing alloy nanoparticles from platinum group metals and other metals under reductive conditions. In particular the present invention relates to a process for producing alloy nanoparticles comprising the steps of mixing a salt of at least one metal, a material comprising a platinum group metal, a nitrogen-rich compound, and optionally a support material, to provide a precursor mixture, and heating said precursor mixture to a temperature of at least 400° C., in the presence of a gas comprising hydrogen (H2), to provide said alloy nanoparticles.

Abstract: The current invention provides a method of activating fibroblast and myofibroblast apoptosis in a tissue of a mammal, comprising administering to the tissue a therapeutically effective amount of a composition comprising an siRNA molecule that binds to an mRNA that codes for TGFB1 protein in a mammalian cell, an siRNA molecule that binds to an mRNA that codes for COX-2 protein in a mammalian cell, and a pharmaceutically acceptable carrier comprising a pharmaceutically acceptable histidine-lysine polymer. The invention also provides additional methods for using this composition.

Abstract: A composition of drug targets and the use the method of using thereof. The composition comprises a vector and a drug using FKBP10 and PCOLCE genes and/or the encoded proteins thereof as drug targets.

Abstract: The invention relates to a method for welding a first workpiece (11) to a second workpiece (12) by means of a laser. It is an object of the invention to provide a reliable, repeatable and reproducible approach for laser welding of two workpieces one of which consists of a semiconductor material.

Abstract: A method for assessing a condition of an organ or tissue of a target object is provided. The method may include: obtaining a target image of the target object; segmenting a target region from the target image, the target region of the target image corresponding to a sub-region of the organ or tissue; determining a morphological characteristic value of the target region in the target image; obtaining a reference standard associated with a sample organ or tissue of a plurality of sample objects, the sample organ or tissue being of a same type as the organ or tissue of the target object; and assessing the condition of the organ or tissue of the target object by comparing the morphological characteristic value of the target region in the target image with the reference standard.

Abstract: Use of glycerol in preparing an adipose tissue cryopreservation protective agent and the adipose tissue cryopreservation protective agent. Based on the total volume of the adipose tissue cryopreservation protective agent, the adipose tissue cryopreservation protective agent includes: glycerol with a volume fraction of 60-80%; 0.090-0.200 g/ml trehalose; and a PBS buffer serving as the solvent. The adipose tissue cryopreservation protective agent is free of DMSO and other protective agents having biological toxicity, poses no toxicity to cells and tissues, and causes no safety problem during clinical use even in a case of incomplete elution. The adipose tissue cryopreservation protective agent is free of xenoantigen and has low cost. With glycerol and trehalose being clinically approved medicinal ingredients and inexpensive products, the agent of the present disclosure contains no costly products such as human albumin, thus providing increased possibility for clinical use and promotion.

Abstract: A method for assessing a condition of an organ or tissue of a target object is provided. The method may include: obtaining a target image of the target object; segmenting a target region from the target image, the target region of the target image corresponding to a sub-region of the organ or tissue; determining a morphological characteristic value of the target region in the target image; obtaining a reference standard associated with a sample organ or tissue of a plurality of sample objects, the sample organ or tissue being of a same type as the organ or tissue of the target object; and assessing the condition of the organ or tissue of the target object by comparing the morphological characteristic value of the target region in the target image with the reference standard.

Abstract: A method for assessing a condition of an organ or tissue of a target object is provided. The method may include: obtaining a target image of the target object; segmenting a target region from the target image, the target region of the target image corresponding to a sub-region of the organ or tissue; determining a morphological characteristic value of the target region in the target image; obtaining a reference standard associated with a sample organ or tissue of a plurality of sample objects, the sample organ or tissue being of a same type as the organ or tissue of the target object; and assessing the condition of the organ or tissue of the target object by comparing the morphological characteristic value of the target region in the target image with the reference standard.

Abstract: The present invention relates to a process for the production of metal alloy nanoparticles which catalyse the oxygen reduction reaction (ORR) for use in proton exchange membrane fuel cells (PEMFC) or electrolyser cells. In particular, the present invention relates to a process for producing alloy nanoparticles from platinum group metals and other metals under reductive conditions. In particular the present invention relates to a process for producing alloy nanoparticles comprising the steps of mixing a salt of at least one metal, a material comprising a platinum group metal, a nitrogen-rich compound, and optionally a support material, to provide a precursor mixture, and heating said precursor mixture to a temperature of at least 400° C., in the presence of a gas comprising hydrogen (H2), to provide said alloy nanoparticles.

Abstract: Providing data processing methods is disclosed, including: receiving a request to provide a plurality of data processing methods to a user; obtaining historical data associated with a plurality of historical user selections associated with the plurality of data processing methods, wherein the plurality of historical user selections is associated with the user; determining a plurality of data processing fingerprint aggregate scores corresponding to respective ones of the plurality of data processing methods based at least in part on the historical data; and providing the plurality of data processing methods based at least in part on the plurality of data processing fingerprint aggregate scores.

Abstract: The current invention provides a method of activating fibroblast and myofibroblast apoptosis in a tissue of a mammal, comprising administering to the tissue a therapeutically effective amount of a composition comprising an siRNA molecule that binds to an mRNA that codes for TGFB1 protein in a mammalian cell, an siRNA molecule that binds to an mRNA that codes for COX-2 protein in a mammalian cell, and a pharmaceutically acceptable carrier comprising a pharmaceutically acceptable histidine-lysine polymer. The invention also provides additional methods for using this composition.

Abstract: Providing data processing methods is disclosed, including: receiving a request to provide a plurality of data processing methods to a user; obtaining historical data associated with a plurality of historical user selections associated with the plurality of data processing methods, wherein the plurality of historical user selections is associated with the user; determining a plurality of data processing fingerprint aggregate scores corresponding to respective ones of the plurality of data processing methods based at least in part on the historical data; and providing the plurality of data processing methods based at least in part on the plurality of data processing fingerprint aggregate scores.

Abstract: A method for assessing a condition of an organ or tissue of a target object is provided. The method may include: obtaining a target image of the target object; segmenting a target region from the target image, the target region of the target image corresponding to a sub-region of the organ or tissue; determining a morphological characteristic value of the target region in the target image; obtaining a reference standard associated with a sample organ or tissue of a plurality of sample objects, the sample organ or tissue being of a same type as the organ or tissue of the target object; and assessing the condition of the organ or tissue of the target object by comparing the morphological characteristic value of the target region in the target image with the reference standard.